The RPS21 Monoclonal Antibody (PAC053042) is a vital tool for researchers studying RPS21, a key protein involved in ribosome biogenesis and translation. This antibody, derived from mouse hybridoma cells, exhibits high specificity and sensitivity towards RPS21 in human samples, making it a valuable asset for experiments such as Western blotting.RPS21 is an essential component of the ribosome, the cellular machinery responsible for protein synthesis. Its role in ribosome assembly and function makes it a relevant target for investigations into various cellular processes, including gene expression regulation and protein production. By specifically recognizing RPS21, this antibody enables researchers to explore the functions and mechanisms of this crucial ribosomal protein in diverse cell types and experimental setups.
With its ability to detect RPS21, the PAC053042 antibody is ideally suited for studies focusing on molecular biology, cell biology, and related fields. By providing insights into the role of RPS21 in cellular physiology and protein synthesis, this antibody contributes to the advancement of scientific knowledge and the development of potential therapeutic strategies targeting ribosome dysfunction in diseases such as cancer and genetic disorders.
Immunohistochemistry of paraffin-embedded human endometrial cancer using PACO53042 at dilution of 1:100.
Immunofluorescent analysis of HepG2 cells using PACO53042 at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
Background:
cytoplasm, cytosol, cytosolic small ribosomal subunit, nucleoplasm, small ribosomal subunit, poly(A) RNA binding, protein N-terminus binding, structural constituent of ribosome, endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA), endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
Synonyms:
40S ribosomal protein S21 (Small ribosomal subunit protein eS21), RPS21
